Egbe Osifo-Dawodu

Anadach Consulting Group

Dr. Egbe Osifo-Dawodu MD, MBA, MSc, MRCP eosifodawodu@anadach.com Dr. Osifo-Dawodu is an entrepreneur, strategist, and visionary. Trained as a physician, she identified early the importance of utilizing management and financial levers to improve health outcomes for populations. Her understanding of management and finance beyond healthcare, and her ability to identify early health (including the impact of COVID) social trends, and risks have made her a highly sought adviser by CEOs, boards, and senior leaders both in the public and private sectors in various countries. Her unique expertise in understanding organizations and people has enabled her to be an effective board member, working collaboratively with the CEO and other board members at MedAccessUK. She is currently the Chair of the People and Remuneration and a member of the Audit and Risk committees of MedAccessUK. Dr. Osifo-Dawodu is a member of the Healthcare Advisory Council of British International Investment (which has directly deployed over $400 million in equity to India and Africa and is a Limited Partner in several Private Equity Funds with over $1.4 billion in investable capital). She was previously an advisory board member of Sproxil (recognized by Fast Company as one of the World’s 50 Most Innovative Companies) the Mayo Clinic Center for Social Media and recognized by Harvard Business School/Scriplogix as one of the most innovative leaders in healthcare. As a founding Partner of the Anadach Group where she leads the Management Consulting and Health Financing Advisory work and her 30+ years of professional experience including 16 years at the World Bank Group working both with senior private and public sector leaders across Asia, Africa, Europe, Latin America, the Middle East, and the USA, she has an effective global network which she has leveraged for her previous board engagements. Dr. Osifo-Dawodu is recognized as a leader and is often invited to speak at conferences, strategic discussions, board retreats, or interviewed on various pharmaceutical, health or technology issues. She is often invited to lecture at leading universities including Columbia, Johns Hopkins, etc. and her work has been published in top academic journals.

Sign up for updates​

Be the first to know when registration launches.

Please enable JavaScript in your browser to complete this form.